View in EDS

Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.

Saved in:
Bibliographic Details
Title: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.
Authors: Bissonnette, Robert1 (AUTHOR) rbissonnette@innovaderm.com, Albreiki, Fatima2 (AUTHOR), Ehst, Benjamin D.3 (AUTHOR), Al Hammadi, Anwar4 (AUTHOR), Schliemann, Sibylle5 (AUTHOR), Yang, Bin6 (AUTHOR), Zhang, Jianzhong7 (AUTHOR), Bunick, Christopher G.8,9 (AUTHOR)
Source: American Journal of Clinical Dermatology. Jan2026, Vol. 27 Issue 1, p199-202. 4p.
Database: Academic Search Ultimate
Description
ISSN:11750561
DOI:10.1007/s40257-025-00974-4